Cargando…

Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP

Pre-exposure prophylaxis (PrEP), antiretroviral medication for prevention of HIV-acquisition, is part of biomedical HIV prevention strategies recommended for people at risk of HIV-infection. A decision to take PrEP depends on an assessment of ‘being at risk’ either by an individual, or healthcare pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawuma, Rachel, Ssemata, Andrew Sentoogo, Bernays, Sarah, Seeley, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873676/
https://www.ncbi.nlm.nih.gov/pubmed/33604448
http://dx.doi.org/10.1016/j.ssmph.2021.100746
_version_ 1783649434107641856
author Kawuma, Rachel
Ssemata, Andrew Sentoogo
Bernays, Sarah
Seeley, Janet
author_facet Kawuma, Rachel
Ssemata, Andrew Sentoogo
Bernays, Sarah
Seeley, Janet
author_sort Kawuma, Rachel
collection PubMed
description Pre-exposure prophylaxis (PrEP), antiretroviral medication for prevention of HIV-acquisition, is part of biomedical HIV prevention strategies recommended for people at risk of HIV-infection. A decision to take PrEP depends on an assessment of ‘being at risk’ either by an individual, or healthcare provider. In this paper, we draw on the concept of ‘candidacy’ to examine the different ways in which women attending a dedicated clinic in Kampala, Uganda, for women at risk of HIV infection (including sex workers), assessed their suitability for PrEP. We conducted in-depth interviews with 30 HIV negative women up to four different times, to gather information on the motives for taking PrEP, and their life history and daily life. All the women described the relevance of PrEP to mitigate their risk of HIV infection. However, there were challenges to adherence because of alcohol use, irregular working hours and a fear of being seen taking pills that others might assume to be HIV treatment. The ways in which the different women used PrEP and interpreted the place of PrEP in their lives were not solely based on their assessment of protecting themselves during sex work. They also used PrEP to guard against infection from their regular partners, and as a tool to allow them to make more money safely, by having sex without a condom with clients. While eligibility to access PrEP was predicated on the women's being in an ‘at risk’ population group, an incentive to use PrEP was to protect themselves from HIV acquisition from a long-term partner and preserve the ‘trust’ in their intimate relationship by having condom-less sex. Applying a candidacy lens we highlight the complexity in how women experience and present as being ‘at risk’ and query the criteria on which categories of risk and PrEP eligibility are determined.
format Online
Article
Text
id pubmed-7873676
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78736762021-02-17 Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP Kawuma, Rachel Ssemata, Andrew Sentoogo Bernays, Sarah Seeley, Janet SSM Popul Health Article Pre-exposure prophylaxis (PrEP), antiretroviral medication for prevention of HIV-acquisition, is part of biomedical HIV prevention strategies recommended for people at risk of HIV-infection. A decision to take PrEP depends on an assessment of ‘being at risk’ either by an individual, or healthcare provider. In this paper, we draw on the concept of ‘candidacy’ to examine the different ways in which women attending a dedicated clinic in Kampala, Uganda, for women at risk of HIV infection (including sex workers), assessed their suitability for PrEP. We conducted in-depth interviews with 30 HIV negative women up to four different times, to gather information on the motives for taking PrEP, and their life history and daily life. All the women described the relevance of PrEP to mitigate their risk of HIV infection. However, there were challenges to adherence because of alcohol use, irregular working hours and a fear of being seen taking pills that others might assume to be HIV treatment. The ways in which the different women used PrEP and interpreted the place of PrEP in their lives were not solely based on their assessment of protecting themselves during sex work. They also used PrEP to guard against infection from their regular partners, and as a tool to allow them to make more money safely, by having sex without a condom with clients. While eligibility to access PrEP was predicated on the women's being in an ‘at risk’ population group, an incentive to use PrEP was to protect themselves from HIV acquisition from a long-term partner and preserve the ‘trust’ in their intimate relationship by having condom-less sex. Applying a candidacy lens we highlight the complexity in how women experience and present as being ‘at risk’ and query the criteria on which categories of risk and PrEP eligibility are determined. Elsevier 2021-01-30 /pmc/articles/PMC7873676/ /pubmed/33604448 http://dx.doi.org/10.1016/j.ssmph.2021.100746 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kawuma, Rachel
Ssemata, Andrew Sentoogo
Bernays, Sarah
Seeley, Janet
Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title_full Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title_fullStr Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title_full_unstemmed Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title_short Women at high risk of HIV-infection in Kampala, Uganda, and their candidacy for PrEP
title_sort women at high risk of hiv-infection in kampala, uganda, and their candidacy for prep
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873676/
https://www.ncbi.nlm.nih.gov/pubmed/33604448
http://dx.doi.org/10.1016/j.ssmph.2021.100746
work_keys_str_mv AT kawumarachel womenathighriskofhivinfectioninkampalaugandaandtheircandidacyforprep
AT ssemataandrewsentoogo womenathighriskofhivinfectioninkampalaugandaandtheircandidacyforprep
AT bernayssarah womenathighriskofhivinfectioninkampalaugandaandtheircandidacyforprep
AT seeleyjanet womenathighriskofhivinfectioninkampalaugandaandtheircandidacyforprep